The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Share News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.375
Bid: 7.25
Ask: 7.50
Change: 0.00 (0.00%)
Spread: 0.25 (3.448%)
Open: 7.375
High: 7.375
Low: 7.375
Prev. Close: 7.375
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: Barkby revenue dips; Ixico hurt by trial delays

Fri, 29th Sep 2023 14:19

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Zanaga Iron Ore Co Ltd - Republic of Congo-focused iron ore exploration and development company - Reports a pretax loss of USD350,000 in the first half of 2023, narrowed from USD526,000 the previous year. Chair Clifford Elphick notes that during the half-year, the company launched a process with an unnamed Chinese iron ore technical expert engineering firm to secure Chinese contractor pricing and to update the cost estimates of the 30 million tonnes per year feasibility study, while also considering the application of new iron ore processing technology to reduce estimated costs further. Looks forward to concluding the process by the year-end. Adds that following the full ownership of the Zanaga project it is now engaging with entities interested in participating in the project. Intends on securing a selected partner by the end of the first quarter of 2024.

----------

Barkby Group PLC - Abingdon, England-based investor in roadside property and in consumer and life sciences companies - Says revenue for the financial year ended June 30 plunges to GBP30,000 from GBP10.3 million a year prior. Loss from continuing operations before tax narrows to GBP2.1 million from GBP5.6 million the year before. Notes "good progress" regarding reorganisation of the company. Executive Chair Charles Dickson says: "Since the beginning of 2023, we have built a significant pipeline of high-quality modern sustainable roadside real estate developments which will comprise drive-thrus, trade counters, last mile logistics, convenience food, [electric vehicle] charging hubs and light industrial commercial uses. Continues to explore funding options to implement its strategy.

----------

MetalNRG PLC - London-based natural resources and energy-focused investor - Reports an operating loss before tax of GBP543,267 in the first half of 2023, narrowed from a loss of GBP999,949 a year prior, as administrative expenses are reduced by 46%. Says that, having addressed most of its legal issues, it can now concentrate on operational matters. Says there are only two legal processes outstanding currently. Adds that its strategic business review has been completed. Confirms its decision to concentrate growth and value creation efforts on the mining sector. "The initial focus will include gold and copper projects, alongside other precious and strategic metals, which face high demand due to global macroeconomic, energy transition, and technology trends," MetalNRG says. Adds that it has also identified a number of potential reverse takeover targets. Also announced on Thursday it will seek a dual listing on the Toronto Stock Exchange following a strategic business review, and will also seek to exit from the Eqtec Italia investment, as it is considered non-core.

----------

Keras Resources PLC - Surrey, England-based mine developer focused on West Africa and the US - Pretax loss in the first half of the year narrows to GBP255,000 from GBP467,000 a year prior as revenue rises by 87% to GBP397,000 from GBP212,000 the year before. This is attributed to a 58% reduction in the cost of production to GBP44,000. Looking ahead, remains "very positive" about the future of Diamond Creek mine in the US state of Utah and the fertiliser market macro-economic conditions that underpin its future. Chair Russell Lamming says: "We are mining an essential resource that can create value, be part of the greener economy and contribute to a more sustainable future. As a mining company we remain ever conscious of our obligations and commitments in line with best environmental, social and governance practice and will continue to take the initiative within this area."

----------

Ixico PLC - London-based precision analytics company delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases - Expects revenue for the financial year ending September 30 to fall 24% to GBP6.5 million from GBP8.6 million the year before, mainly reflected by the final year impact of the early cessation of large client trials, as well as delays in client trial initiations. Expects order book for financial 2023 to have grown to at least GBP14.5 million from GBP13.3 million a year prior. Anticipates full-year earnings before interest, tax, depreciation and amortisation to improve on current expectations of a GBP1.0 million loss, compared to a GBP1.5 million Ebitda profit in financial 2022. Chief Executive Officer Giulio Cerroni says: "I am proud of Ixico's achievements reflected by the strengthening of the orderbook since the half year. Given the significant and growing unmet need for new therapies across a wide range of neurological diseases, I remain confident of the runway for growth for Ixico's specialist neuroimaging services, underpinned by the increasing inclusion of imaging biomarkers in neurodegeneration clinical trials."

----------

MS International PLC - Doncaster, England based defence equipment manufacturer - Says South Carolina-based subsidiary MSI-Defence Systems US LLC receives a USD23.5 million contract from the US Navy for the supply of MSI-DS 30mm gun mounts. Says delivery of equipment is scheduled for no later than December 18, 2024.

----------

By Sabrina Penty, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
20 Oct 2016 11:01

Ixico pens deal to help develop a therapy for Parkinson's like diesease

(ShareCast News) - Shares in AIM-listed Ixico rose above 22% on Thursday, as the brain health company announced it had signed a $1.2m contract with a global pharmaceutical for imaging clinical trial services for a Parkinson's-like neurodegenerative disease. The project is for a second phase clinical

Read more
10 Oct 2016 12:26

Ixico to receive €1m from EU Alzheimer's project

(ShareCast News) - AIM-listed pharmaceutical Ixico is to receive €1m as a partner in an EU public-private consortium, which has the potential for long-term revenue through the development of diagnostic and disease management technologies for Alzheimer's. Ixico is to work on the Amyloid Imaging to Pr

Read more
2 Jun 2016 16:27

IXICO study joins Dementias Platform

(ShareCast News) - Brain health company IXICO announced on Thursday that its Cygnus study has joined the high-profile Dementias Platform UK (DPUK). The AIM-traded firm described Cygnus as a real-world digital data collection study from people with cognitive impairment and dementia. It said the four

Read more
18 Jan 2016 13:51

Ixico wins four new contracts worth over £3m

(ShareCast News) - Brain health company Ixico was recently awarded four new contracts with "leading" pharmaceutical groups and a specialist biotechnology firm totalling over £3m in value. The contracts involve global clinical trials of novel drugs for Alzheimer's disease spanning three major phases

Read more
19 Oct 2015 12:33

Ixico full-year income in line with expectations

(ShareCast News) - Brain health company Ixico reported revenues for the year of £3.1m and other income at £1m, in line with market expectations and giving a total combined income of £4.1m. This was down from £4.3m for the 16-month period to 30 September 2014. In a pre-close trading update ahead of

Read more
29 Jun 2015 11:11

Ixico secures two clinical trial contracts alongside partner VirtualScopics

Ixico has won two contracts to deploy its products in unnamed pharmaceutical companies' clinical trials, alongside its partner VirtualScopics. Both studies will employ Ixico's TrialTracker digital platform to collect and image data, one pertaining to metastatic solid tumours and the other to rare ne

Read more
17 Sep 2014 08:48

IXICO Appoints CFO For October 1 Start

Read more
21 Jul 2014 15:45

DIRECTOR DEALINGS: IXICO Divisional Vice-President Buys Shares

Read more
18 Jul 2014 07:25

UK MORNING BRIEFING: Shares Lower On Ukraine Crash, Gaza Offensive

Read more
19 Jun 2014 10:40

IXICO Joins Medical Research Council Collaboration For Dementia Drive

LONDON (Alliance News) - IXICO PLC said Thursday it will take part in a GBP16 million collaboration launched by publicly funded government agency the Medical Research Council to speed up research into dementia. The MRC has launched the UK Dementias Research Platform with the aim of seeking

Read more
19 Jun 2014 08:30

Ixico partners with the Medical Research Council to launch UK Dementias Research Platform

Biotechnology group Ixico has partnered with the Medical Research Council (MRC) to launch the UK Dementias Research Platform (UKDP), a £16m public-private partnership. The group, which set up the partnership to speed up research into dementias, will act as the MRC's imaging partner on the project a

Read more
6 Jun 2014 09:20

IXICO To Meet Full-Year Expectations As Interim Hit By Listing Costs

LONDON (Alliance News) - IXICO PLC expressed confidence Friday in meeting market expectations for the full year, as it swung into a loss in the half year to end-March, hit by costs relating to its AIM listing and a decline in revenues. The company was formed via the reverse takeover of Phyt

Read more
22 May 2014 12:07

IXICO Wins Contracts For Huntington's Disease Clinical Trials

LONDON (Alliance News) - Brain health company IXICO PLC Thursday said it has won contracts for two separate clinical trials in Huntington's disease with "top 15" pharmaceutical companies, building on a third clinical study already underway on the disease. In a statement, IXICO said the two

Read more
16 Apr 2014 09:54

IXICO Awarded Development Contract By NHS England Initiative

LONDON (Alliance News) - IXICO PLC Wednesday said it has been awarded a development contract by The Small Business Research Initiative for Healthcare, an NHS England initiative, to cover phase 1 funding for the development of an online application designed to support dementia sufferers after they

Read more
16 Apr 2014 07:33

UK MORNING BRIEFING: RSA Loses UK & Western Europe Chief Executive

LONDON (Alliance News) - RSA Insurance Group said Wednesday the Chief Executive of the business which houses its troubled Irish operations has resigned in order to become Executive Chairman, underwriting and distribution, at business partner A J.Gallagher. The company said UK & Western Euro

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.